Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Expanding Accelerated Approval Through Guidance, Collaboration

12 Mar 2012

• By Cathy Dombrowski

Related Content

FDA Biomedical Innovation Initiative Draws On Familiar Themes

10 Oct 2011

“Adaptive Licensing” Proposals View REMS As Answer To Limited Evidence

12 Mar 2012

FDA Antibiotic Legislation Should Focus On Criteria, Not Bacteria, Woodcock Says

08 Mar 2012

Alzheimer’s Plan Emphasizes Acceleration, Sets Timeline On Prevention, Cure

27 Feb 2012

Rare Diseases Need Ongoing Natural History Studies To Speed Trials, FDA Says

14 Nov 2011

Additional Topics

United States Drug Approval Standards Regulation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.